INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

75,427 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SM
Schrum MichaelChief Financial Officer
NTBBank of N.T. Butterfield & Son Ltd
Grant or award
A—
1,328 sh
Aug 26, 2026Aug 27, 2026
Page 549 of 1886
← PrevNext →
traded Aug 26, 2026
+1d
SEC Form 4

Evidence

9
CW
Collins Michael WChief Executive Officer
NTBBank of N.T. Butterfield & Son Ltd
Grant or award
A—
2,700 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
31.0K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
CA
Ciongoli Gregory AustinDirector
RGNXREGENXBIO Inc.
Grant or award
A—
69.6K sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
31.0K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
BR
Burns Andrew RonaldChief Risk Officer, Cayman
NTBBank of N.T. Butterfield & Son Ltd
Grant or award
A—
50 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
BV
Bali VinitaDirector
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Grant or award
A—
22 sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
MM
McWatt MichaelManaging Director, Cayman
NTBBank of N.T. Butterfield & Son Ltd
Grant or award
A—
492 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
18.4K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
MC
Moeller Timothy CSr. Vice President
TTITETRA TECHNOLOGIES INC
Option exercise
M—
13.6K sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
SA
Schot AbrahamDirector
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Grant or award
A—
22 sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
TC
Thota ChandrasekharDirector
DTDynatrace, Inc.
Grant or award
A—
379 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
SA
Samuels Michele AnnetteDirector
HBNCHORIZON BANCORP INC /IN/
Grant or award
A$6,258
306 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
AA
Alonso Andres ADirector
SCHLSCHOLASTIC CORP
Option exercise
M—
2,112 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
DS
Douglass Jeffrey SVP, MARKETING
WEYSWEYCO GROUP INC
Tax withholding
F$20K
438 sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
KS
Kapoor Shivpreet SinghDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
18.4K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
NY
Nechmad YairDirector, CEO, Co Founder & Chairman
NYAXNayax Ltd.
Option exercise
M—
75.0K sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
2,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
NW
Neff Michael WalterChief Operating Officer
NTBBank of N.T. Butterfield & Son Ltd
Grant or award
A—
49 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
MM
McWatt MichaelManaging Director, Cayman
NTBBank of N.T. Butterfield & Son Ltd
Grant or award
A—
61 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
KS
Kornfeld StevenDirector
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
18.4K sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
SM
Sanderson MatthewExecutive Vice President & CFO
TTITETRA TECHNOLOGIES INC
Option exercise
M—
14.6K sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
SM
Schrum MichaelChief Financial Officer
NTBBank of N.T. Butterfield & Son Ltd
Grant or award
A—
1,455 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
WP
Williams Vanessa PetersonDirector
HBNCHORIZON BANCORP INC /IN/
Grant or award
A$6,258
306 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
MM
Murphy Brady MPresident & CEO
TTITETRA TECHNOLOGIES INC
Option exercise
M—
58.3K sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
PJ
Pearce JaneManaging Director, Trust
NTBBank of N.T. Butterfield & Son Ltd
Grant or award
A—
330 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
KA
Kulkarni AmolDirector
DTDynatrace, Inc.
Grant or award
A—
4,458 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
SG
Sotiros GeorgeVP - INFORMATION SYSTEMS
WEYSWEYCO GROUP INC
Grant or award
A—
1,360 sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
BC
Brun Scott C.Director
FBRXForte Biosciences, Inc.
Disposition to issuer
D—
1,000 sh
Aug 27, 2026Aug 27, 2026
traded Aug 27, 2026
+0dSEC Form 4

Evidence

9
SM
Sanderson MatthewExecutive Vice President & CFO
TTITETRA TECHNOLOGIES INC
Option exercise
M—
15.1K sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
AK
Ahern KevinDirector
HBNCHORIZON BANCORP INC /IN/
Grant or award
A$6,258
306 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
WO
Wolberg Kirsten O.Director
DTDynatrace, Inc.
Grant or award
A—
4,458 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
MW
Maass Brian WDirector
HBNCHORIZON BANCORP INC /IN/
Grant or award
A$6,258
306 sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
MM
Murphy Brady MPresident & CEO
TTITETRA TECHNOLOGIES INC
Option exercise
M—
60.5K sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
CA
Ciongoli Gregory AustinDirector
RGNXREGENXBIO Inc.
Grant or award
A—
15.4K sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence

9
NY
Nechmad YairDirector, CEO, Co Founder & Chairman
NYAXNayax Ltd.
Option exercise
M—
15.6K sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC Form 4

Evidence

9
NS
Nilsson StefanPresident, Nobel Biocare
NVSTEnvista Holdings Corp
Tax withholding
F$22K
804 sh
Aug 25, 2026Aug 27, 2026
traded Aug 25, 2026
+2dSEC Form 4

Evidence